Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bitulac is a probiotic and multivitamin combination product developed by Amvia Biotech, primarily intended for paediatric gut flora support and nutritional supplementation. It contains Lactic Acid Bacillus spores, which serve as a probiotic to restore and maintain a healthy intestinal microbiome, particularly following antibiotic use or diarrheal illness. The formulation is further enriched with B-complex vitamins, folic acid, and niacinamide to support metabolic processes, energy production, and overall growth in children. Bitulac is available in oral capsule and dry syrup forms, with the dry syrup specifically tailored for paediatric administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bitulac.